Repository of Research and Investigative Information

Repository of Research and Investigative Information

Zahedan University of Medical Sciences

The road to biosimilars in rare diseases - ongoing lessons from Gaucher disease

(2019) The road to biosimilars in rare diseases - ongoing lessons from Gaucher disease. Am J Hematol. ISSN 0361-8609

[img] Text
ajh.25701.pdf

Download (986kB)

Official URL: https://www.ncbi.nlm.nih.gov/pubmed/?term=(2019)+T...

Abstract

A‘biosimilar’is a biotherapeutic product that has provensimilarity interms of quality, safety and efficacy to a licensed reference product(RP) (Table 1). The term‘biosimilar’was introduced for biologicsbecause their complexity makes it impossible to make an identicalcopy. In contrast, a‘generic’is an exact copy of a small-molecule drugwith a known chemical structure and a fixed number of atoms. Withpatent expiries of biologics, biosimilars have been proclaimed as ameans to broaden access to treatment and reduce costs.

Item Type: Article
Keywords: , Gaucher disease rare diseases
Subjects: WH Hemic and Lymphatic Systems > WH 120-540 Hematologic Diseases. Immunologic Factors. Blood Banks
Journal or Publication Title: Am J Hematol
Journal Index: Pubmed
Identification Number: https://doi.org/10.1002/ajh.25701
ISSN: 0361-8609
Depositing User: خانم مهدیه رضائی پور
URI: http://eprints.zaums.ac.ir/id/eprint/3617

Actions (login required)

View Item View Item